CN Patent

CN107857768A — 一种埃格列净新晶型

Assigned to Weihai Guanbiao Information Technology Co Ltd · Expires 2018-03-30 · 8y expired

What this patent protects

本发明涉及一种埃格列净新晶型，属于原料药制备技术领域。本发明所述埃格列净新晶型，所述晶型的X射线粉末衍射在2θ为7.45,9.35,10.80,13.62,14.76,18.50,19.62,20.88,21.76,24.32,25.10位置有较强吸收峰。本发明提供了一种具有很好溶解度且稳定的埃格列净新晶型，为埃格列净制剂的制备提供了好的原料药。

USPTO Abstract

本发明涉及一种埃格列净新晶型，属于原料药制备技术领域。本发明所述埃格列净新晶型，所述晶型的X射线粉末衍射在2θ为7.45,9.35,10.80,13.62,14.76,18.50,19.62,20.88,21.76,24.32,25.10位置有较强吸收峰。本发明提供了一种具有很好溶解度且稳定的埃格列净新晶型，为埃格列净制剂的制备提供了好的原料药。

Drugs covered by this patent

Patent Metadata

Patent number
CN107857768A
Jurisdiction
CN
Classification
—
Expires
2018-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Weihai Guanbiao Information Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.